In several tumors, such as colorectal cancer and follicular lymphoma, low numbers of tumor-infiltrating mast cells predicted prolonged OS [68, 69], and in melanoma, tumor-infiltrating mast cells have been shown to co-localize with Tregs and have also been associated with resistance to anti-PD1 therapy [70]. Here, PDCD1 is linked to neoplasm.